Clinical extracorporeal hybrid liver support -: phase I study with primary porcine liver cells

被引:119
作者
Sauer, IM
Kardassis, D
Zeillinger, K
Pascher, A
Gruenwald, A
Pless, G
Irgang, M
Kraemer, M
Puhl, G
Frank, J
Müller, AR
Steinmüller, T
Denner, J
Neuhaus, P
Gerlach, JC
机构
[1] Humboldt Univ, Klin Allgemein Viszeral & Transplantat Chirurg, Charite, D-13353 Berlin, Germany
[2] Robert Koch Inst, D-1000 Berlin, Germany
[3] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA
关键词
artificial liver support; acute liver failure; bioreactor; clinical study; hybrid liver support;
D O I
10.1034/j.1399-3089.2003.00062.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The objective of this study was to evaluate the feasibility and safety of a hybrid liver support system with extracorporeal plasma separation and bioreactor perfusion in patients with acute liver failure (ALF) who had already fulfilled the criteria for high urgency liver transplantation (LTx). Eight patients (one male, seven female) were treated in terms of bridging to transplantation. The mean age was 36.5 yr (range 20 to 58). Etiology of liver failure was drug-related in two patients, hepatitis B infection in three patients, and unknown for three patients. The bioreactors were charged with primary liver cells from specific pathogen-free pigs. Cell viability varied between 91 and 98%. Continuous liver support treatment over a period of 8 to 46 h (mean 27.3 h) was safely performed and well-tolerated by all patients. No complications associated with the therapy were observed during the follow-up period. Thrombocytopenia was considered to be an effect of the plasma separation. Subsequently, all patients were transplanted successfully and were observed over at least 3 yr with an organ and patient survival rate of 100%. Screening of patient's sera for antibodies specific for porcine endogenous retroviruses (PERVs) showed no reactivity - either prior to application of the system, or after extracorporeal treatment. The results encourage us to continue the development of the technology, and further studies appear to be justified. The bioreactor technology has been integrated into a modular extracorporeal liver support (MELS) system, combining biologic liver support with artificial detoxification technology.
引用
收藏
页码:460 / 469
页数:10
相关论文
共 20 条
[1]   Support of the acutely failing liver - State of the art [J].
Demetriou, AA .
ANNALS OF SURGERY, 1998, 228 (01) :14-15
[2]   Immunosuppression by retroviruses: Implications for xenotransplantation [J].
Denner, J .
XENOTRANSPLANTATION: SCIENTIFIC FRONTIERS AND PUBLIC POLICY, 1998, 862 :75-86
[3]   Artificial liver support in acute liver failure [J].
Dowling, DJ ;
Mutimer, DJ .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (09) :991-996
[4]   High yield hepatocyte isolation from pig livers for investigation of hybrid liver support systems: Influence of collagenase concentration and body weight [J].
Gerlach, J ;
Brombacher, J ;
Smith, M ;
Neuhaus, P .
JOURNAL OF SURGICAL RESEARCH, 1996, 62 (01) :85-89
[5]   IMPROVED HEPATOCYTE IN-VITRO MAINTENANCE IN A CULTURE MODEL WITH WOVEN MULTICOMPARTMENT CAPILLARY SYSTEMS - ELECTRON-MICROSCOPY STUDIES [J].
GERLACH, JC ;
SCHNOY, N ;
ENCKE, J ;
SMITH, MD ;
MULLER, C ;
NEUHAUS, P .
HEPATOLOGY, 1995, 22 (02) :546-552
[6]   BIOREACTOR FOR A LARGER SCALE HEPATOCYTE IN-VITRO PERFUSION [J].
GERLACH, JC ;
ENCKE, J ;
HOLE, O ;
MULLER, C ;
RYAN, CJ ;
NEUHAUS, P .
TRANSPLANTATION, 1994, 58 (09) :984-988
[7]   Experimental evaluation of a cell module for hybrid liver support [J].
Gerlach, JC ;
Botsch, M ;
Kardassis, D ;
Lemmens, P ;
Schön, M ;
Janke, J ;
Puhl, G ;
Unger, J ;
Kraemer, M ;
Busse, B ;
Böhmer, C ;
Belal, R ;
Ingenlath, M ;
Kosan, M ;
Kosan, B ;
Sültmann, J ;
Patzold, A ;
Tietze, S ;
Rossaint, R ;
Müller, C ;
Mönch, E ;
Sauer, IM ;
Neuhaus, P .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2001, 24 (11) :793-798
[8]   Monitoring xenotransplant recipients for infection by PERV [J].
Herring, C ;
Cunningham, DA ;
Whittam, AJ ;
Fernández-Suárez, XM ;
Langford, GA .
CLINICAL BIOCHEMISTRY, 2001, 34 (01) :23-27
[9]   COAGULOPATHY OF FULMINANT HEPATIC-FAILURE [J].
OGRADY, JG ;
LANGLEY, PG ;
ISOLA, LM ;
ALEDORT, LM ;
WILLIAMS, R .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :159-163
[10]   Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience [J].
Pascher, A ;
Sauer, IM ;
Hammer, C ;
Gerlach, JC ;
Neuhaus, P .
XENOTRANSPLANTATION, 2002, 9 (05) :309-324